{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T23:00:33Z","timestamp":1747090833883},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"39 (4)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,11]]},"DOI":"10.12788\/fp.0247","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T17:45:28Z","timestamp":1650044728000},"source":"Crossref","is-referenced-by-count":2,"title":["Neutropenia and Leukopenia After Cross Taper From Quetiapine to Divalproex for the Treatment of Borderline Personality Disorder"],"prefix":"10.12788","author":[{"given":"Caroline","family":"Richmond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","container-title":["Federal Practitioner"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/issues\/articles\/fdp03904182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T17:45:29Z","timestamp":1650044729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/fedprac\/article\/253593\/hematologic-malignancies\/neutropenia-and-leukopenia-after-cross-taper"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":0,"journal-issue":{"issue":"39 (4)","published-print":{"date-parts":[[2022,4,11]]}},"URL":"https:\/\/doi.org\/10.12788\/fp.0247","relation":{},"subject":[],"published":{"date-parts":[[2022,4,11]]}}}